Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, biomedical publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs). These EVs are known to mediate many of the therapeutic effects of stem cells. Austrianova’s proprietary Cell-in-a-Box encapsulation technology is used to produce and purify EVs from Cells for Cell’s proprietary MSCs. The publication by Zavala et al, which was co-authored with their academic partners, the University of Veterinary Medicine Vienna, Austria and the University of the Andes, Chile appeared as part of a special stem cell issue of the prestigious international journal “Frontiers in Pharmacology” https://doi.org/10.3389/fphar.2020.00679
